Figure. Cumulative hazard of cardiovascular disease (CVD) stratified by use of renin–angiotensin system inhibitors (RAS inhibitors) over time. Legends: A, Exclusion of immortal time among the user cohort without re-inclusion of it among the nonuser cohort; B, Exclusion of immortal time among the user cohort and re-inclusion of it to the nonuser cohort. The 2 plots were adjusted for baseline covariables, shown in Table 2.